Home/Filings/4/0000882104-20-000048
4//SEC Filing

Stone Christopher Lewis 4

Accession 0000882104-20-000048

CIK 0000882104other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 8:48 AM ET

Size

5.9 KB

Accession

0000882104-20-000048

Insider Transaction Report

Form 4
Period: 2019-12-12
Stone Christopher Lewis
VP and General Counsel
Transactions
  • Tax Payment

    Common stock

    2019-12-12$3.43/sh1,240$4,253619,789 total
  • Tax Payment

    Common stock

    2019-12-16$3.33/sh2,686$8,944617,103 total

Issuer

PDL BIOPHARMA, INC.

CIK 0000882104

Entity typeother

Related Parties

1
  • filerCIK 0001453373

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 8:48 AM ET
Size
5.9 KB